SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Joseph G. Taylor, John G. Gribben, Microenvironment abnormalities and Lymphomagenesis: Immunological aspects, Seminars in Cancer Biology, 2015,

    CrossRef

  2. 2
    Kristine Niss Arfelt, Suzan Fares, Mette M. Rosenkilde, The Molecular Basis of Viral Infection, 2015,

    CrossRef

  3. 3
    Liping Ma, Shan Li, Yu Lu, Xiaolian Zhang, Jiangyang Zhao, Xue Qin, A pooled analysis of the IL-10-1082 A/G polymorphism and the nasopharyngeal carcinoma susceptibility, European Archives of Oto-Rhino-Laryngology, 2014,

    CrossRef

  4. 4
    Laurissa Ouaguia, Dhafer Mrizak, Sarah Renaud, Olivier Moralès, Nadira Delhem, Control of the Inflammatory Response Mechanisms Mediated by Natural and Induced Regulatory T-Cells in HCV-, HTLV-1-, and EBV-Associated Cancers, Mediators of Inflammation, 2014, 2014, 1

    CrossRef

  5. 5
    Hugo Sousa, Eduardo Breda, Alexandra M. Santos, Raquel Catarino, Daniela Pinto, Paulo Canedo, José Carlos Machado, Rui Medeiros, IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal, Archives of Oral Biology, 2013, 58, 8, 1040

    CrossRef

  6. 6
    Viviana P. Lutzky, Denis J. Moss, Vaccines, 2013,

    CrossRef

  7. 7
    C S Tudor, C W Dawson, J Eckhardt, G Niedobitek, A C Büttner, B Seliger, A Hartmann, M Buettner, c-Myc and EBV–LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cells, British Journal of Cancer, 2012, 106, 12, 1980

    CrossRef

  8. 8
    Debora Martorelli, Elena Muraro, Anna Merlo, Riccardo Turrini, Damiana Antonia Faè, Antonio Rosato, Riccardo Dolcetti, Exploiting the Interplay between Innate and Adaptive Immunity to Improve Immunotherapeutic Strategies for Epstein-Barr-Virus-Driven Disorders, Clinical and Developmental Immunology, 2012, 2012, 1

    CrossRef

  9. 9
    Claire Gourzones, Clément Barjon, Pierre Busson, Host–tumor interactions in nasopharyngeal carcinomas, Seminars in Cancer Biology, 2012, 22, 2, 127

    CrossRef

  10. 10
    Christopher W. Dawson, Rebecca J. Port, Lawrence S. Young, The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC), Seminars in Cancer Biology, 2012, 22, 2, 144

    CrossRef

  11. 11
    Zhi-Hui Yang, Qiong Dai, Li Zhong, Xu Zhang, Qing-Xi Guo, Shi-Ning Li, Association of IL-1 polymorphisms and IL-1 serum levels with susceptibility to nasopharyngeal carcinoma, Molecular Carcinogenesis, 2011, 50, 3
  12. 12
    Hugo Sousa, Eduardo Breda, Alexandra M. Santos, Raquel Catarino, Daniela Pinto, Rui Medeiros, Genetic Risk Markers for Nasopharyngeal Carcinoma in Portugal: Tumor Necrosis Factor Alpha −308G >A Polymorphism, DNA and Cell Biology, 2011, 30, 2, 99

    CrossRef

  13. 13
    Ho-Kee Koon, Kwok-Wai Lo, Kwok-Nam Leung, Maria Li Lung, Chris Chi-Kwong Chang, Ricky Ngok-Shun Wong, Wing-Nang Leung, Nai-Ki Mak, Photodynamic therapy-mediated modulation of inflammatory cytokine production by Epstein–Barr virus-infected nasopharyngeal carcinoma cells, Cellular and Molecular Immunology, 2010, 7, 4, 323

    CrossRef

  14. 14
    Randy D. Gascoyne, Andreas Rosenwald, Sibrand Poppema, Georg Lenz, Prognostic biomarkers in malignant lymphomas, Leukemia & Lymphoma, 2010, 51, S1, 11

    CrossRef

  15. 15
    Fathima Zumla Cader, Pamela Kearns, Lawrence Young, Paul Murray, Martina Vockerodt, The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas, Cancer Treatment Reviews, 2010, 36, 4, 348

    CrossRef

  16. 16
    Ewa Bien, Anna Balcerska, Elzbieta Adamkiewicz-Drozynska, Malgorzata Rapala, Malgorzata Krawczyk, Jan Stepinski, Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias, Clinical Biochemistry, 2009, 42, 10-11, 1144

    CrossRef

  17. 17
    Yvette L. Kasamon, Richard F. Ambinder, Immunotherapies for Hodgkin's lymphoma, Critical Reviews in Oncology/Hematology, 2008, 66, 2, 135

    CrossRef

  18. 18
    K. Farhat, E. Hassen, S. Gabbouj, N. Bouaouina, L. Chouchane, Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma, International Journal of Immunogenetics, 2008, 35, 3
  19. 19
    Marijke Niens, Lydia Visser, Ilja M. Nolte, Gerrit Van Der Steege, Arjan Diepstra, Pablo Cordano, Ruth F. Jarrett, Gerard J. Te Meerman, Sibrand Poppema, Anke Van Den Berg, Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22, British Journal of Haematology, 2008, 140, 5
  20. 20
    Hela Ben Nasr, Karim Chahed, Souhir Mestiri, Noureddine Bouaouina, Kaouther Snoussi, Lotfi Chouchane, Association of IL-8 (−251)T/A polymorphism with susceptibility to and aggressiveness of nasopharyngeal carcinoma, Human Immunology, 2007, 68, 9, 761

    CrossRef

  21. 21
    Maike Buettner, Nicole Heussinger, Gerald Niedobitek, Expression of Epstein–Barr virus (EBV)-encoded latent membrane proteins and STAT3 activation in nasopharyngeal carcinoma, Virchows Archiv, 2006, 449, 5, 513

    CrossRef

  22. 22
    Herbst Hermann, Niedobitek Gerald, Epstein-Barr Virus, 2006,

    CrossRef

  23. 23
    Martina Teichmann, Birgit Meyer, Andreas Beck, Gerald Niedobitek, Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma, The Journal of Pathology, 2005, 206, 1
  24. 24
    S. Rivera, C. Keryer, P. Busson, P. Maingon, Les carcinomes du nasopharynx : de la biologie à la clinique, Cancer/Radiothérapie, 2005, 9, 1, 55

    CrossRef

  25. 25
    G. Muti, V. Mancini, E. Ravelli, E. Morra, Significance of Epstein-Barr virus (EBV) load and Interleukin-10 in post-transplant lymphoproliferative disorders, Leukemia & Lymphoma, 2005, 46, 10, 1397

    CrossRef

  26. 26
    S. Stewart, C. W. Dawson, K. Takada, J. Curnow, C. A. Moody, J. W. Sixbey, L. S. Young, Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF- B transcription factor pathway, Proceedings of the National Academy of Sciences, 2004, 101, 44, 15730

    CrossRef

  27. 27
    Huaizhong Hu, Kin Fai Tang, Yen Ni Chua, Jinhua Lu, Ping Feng, Chuan Tieh Chew, Soh Ha Chan, Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration, Human Pathology, 2004, 35, 6, 722

    CrossRef

  28. 28
    Gabriele Siegler, Birgit Meyer, Chris Dawson, Elena Brachtel, Jochen Lennerz, Claudia Koch, Elisabeth Kremmer, Edith Niedobitek, Roberta Gonnella, Ben Z. Pilch, Lawrence S. Young, Gerald Niedobitek, Expression of tumor necrosis factor receptor–associated factor 1 in nasopharyngeal carcinoma: Possible upregulation by Epstein-Barr virus latent membrane protein 1, International Journal of Cancer, 2004, 112, 2
  29. 29
    Ruth Holm, Microbial Imaging, 2004,

    CrossRef

  30. 30
    Jaap M. Middeldorp, Antoinette A.T.P Brink, Adriaan J.C van den Brule, Chris J.L.M Meijer, Pathogenic roles for Epstein–Barr virus (EBV) gene products in EBV-associated proliferative disorders, Critical Reviews in Oncology/Hematology, 2003, 45, 1, 1

    CrossRef

  31. 31
    Riccardo Dolcetti, Jose Menezes, 2003,

    CrossRef

  32. 32
    Alain P Vicari, Christophe Caux, Chemokines in cancer, Cytokine & Growth Factor Reviews, 2002, 13, 2, 143

    CrossRef

  33. 33
    Ewerton M. Maggio, Anke Van den Berg, Lydia Visser, Arjan Diepstra, Joust Kluiver, Roelke Emmens, Sibrand Poppema, Common and differential chemokine expression patterns in rs cells of NLP, EBV positive and negative classical hodgkin lymphomas, International Journal of Cancer, 2002, 99, 5
  34. 34
    Johann Fleischmann, Elisabeth Kremmer, John S. Greenspan, Friedrich A. Grässer, Gerald Niedobitek, Expression of viral and human dUTPase in Epstein-Barr virus-associated diseases, Journal of Medical Virology, 2002, 68, 4
  35. 35
    Gerald Niedobitek, Doreen Päzolt, Martina Teichmann, Odile Devergne, Frequent expression of the Epstein–Barr virus (EBV)-induced gene, EBI3, an IL-12 p40-related cytokine, in Hodgkin and Reed–Sternberg cells, The Journal of Pathology, 2002, 198, 3
  36. 36
    Joost J Oudejans, Hari Harijadi, J Alain Kummer, I Bing Tan, Elizabeth Bloemena, Jaap M Middeldorp, Belinda Bladergroen, Danny F Dukers, Wim Vos, Chris JLM Meijer, High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent, The Journal of Pathology, 2002, 198, 4
  37. 37
    Shouichi Ohga, Akihiko Nomura, Hidetoshi Takada, Toshiro Hara, Immunological aspects of Epstein–Barr virus infection, Critical Reviews in Oncology/Hematology, 2002, 44, 3, 203

    CrossRef

  38. 38
    Steven P Lee, Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy, Seminars in Cancer Biology, 2002, 12, 6, 463

    CrossRef